Morales José A, López Ruth M, López Jorge S, Lozano Jair, Jarillo Rosa A, Flores Héctor, Castillo Enrique F
Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Ciudad de México, México.
Departamento de Biología Celular, Instituto Nacional de Perinatología, Ciudad de México, México.
Iran J Basic Med Sci. 2020 Aug;23(8):1091-1099. doi: 10.22038/ijbms.2020.44776.10451.
To determine the effects of triiodothyronine (T3) intracoronary perfusion in isolated hearts and short-term administration in rats on the left ventricular (LV) phosphorylation patterns of Akt and ERK1/2.
Cardiodynamic and hemodynamic parameters were evaluated in Langendorff-perfused hearts. Left ventricles were used for histomorphometric and Western blot analyses. Short-term hyperthyroidism was established by T3 (500 μg.kg.d; subcutaneous injection) for 1 (T3), 3 (T3), and 10 (T3) days.
Isolated hearts receiving T3 perfusion did not modify LV developed pressure, +dP/dt, -dP/dt, heart rate, and coronary perfusion pressure compared with vehicle-perfused hearts. P-ERK1/2 and p-Akt levels in LV tissues after 5, 15, or 60 min of T3 or vehicle perfusion were similar. Compared with their time-matched controls, isolated hearts of T3 and T3 rats exhibited LV hypertrophy and increased absolute values of +dP/dt and -dP/dt (i.e., positive inotropic and lusitropic effects). P-ERK1/2 decreased in LV tissues of T3 and T3 but not in those of T3 rats, and p-Akt levels augmented in left ventricles of T3 and stayed unaltered in those of T3 and T3 rats.
T3 intracoronary perfusion did not alter cardiodynamics and hemodynamics nor influence the activation of Akt and ERK of normal hearts. Accordingly, the rapid non-genomic effects of T3 were not evident. Short-term T3 treatment provoked cardiac hypertrophy coincidental with increased LV function and associated with transient Akt activation and cyclic ERK1/2 inhibition; which implies activation of physiological hypertrophy signaling and deactivation of pathological hypertrophy signaling, respectively.
确定三碘甲状腺原氨酸(T3)冠状动脉内灌注对离体心脏的影响以及对大鼠短期给药后左心室(LV)中Akt和ERK1/2磷酸化模式的影响。
在Langendorff灌注心脏中评估心脏动力学和血流动力学参数。左心室用于组织形态计量学和蛋白质免疫印迹分析。通过皮下注射T3(500μg·kg·d)建立短期甲状腺功能亢进状态,持续1天(T3)、3天(T3)和10天(T3)。
与灌注赋形剂的心脏相比,接受T3灌注的离体心脏在左心室舒张末压、+dP/dt、-dP/dt、心率和冠状动脉灌注压方面没有改变。T3或赋形剂灌注5、15或60分钟后,LV组织中的P-ERK1/2和p-Akt水平相似。与相应的时间匹配对照组相比,T3和T3大鼠的离体心脏表现出左心室肥厚,+dP/dt和-dP/dt的绝对值增加(即正性变力和变时效应)。T3和T3大鼠LV组织中的P-ERK1/2降低,但T3大鼠未降低,T3和T3大鼠左心室中的p-Akt水平增加,而T3大鼠左心室中的p-Akt水平保持不变。
T3冠状动脉内灌注不会改变心脏动力学和血流动力学,也不会影响正常心脏中Akt和ERK的激活。因此,T3的快速非基因组效应不明显。短期T3治疗引起心脏肥大,同时左心室功能增强,并与Akt的短暂激活和ERK1/2的周期性抑制相关;这分别意味着生理性肥大信号的激活和病理性肥大信号的失活。